Two Seas Capital LP Acquires 2,496,136 Shares of Sotera Health (NASDAQ:SHC)

Two Seas Capital LP lifted its stake in shares of Sotera Health (NASDAQ:SHC - Free Report) by 624.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 2,896,136 shares of the company's stock after buying an additional 2,496,136 shares during the quarter. Sotera Health comprises about 3.4% of Two Seas Capital LP's holdings, making the stock its 9th biggest holding. Two Seas Capital LP owned 1.02% of Sotera Health worth $39,619,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also modified their holdings of the stock. Blue Trust Inc. grew its position in shares of Sotera Health by 164.3% during the fourth quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock worth $25,000 after acquiring an additional 1,140 shares during the last quarter. GAMMA Investing LLC grew its position in Sotera Health by 37.5% during the 4th quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after purchasing an additional 1,121 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in Sotera Health by 37.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after purchasing an additional 1,640 shares during the period. Sterling Capital Management LLC raised its holdings in shares of Sotera Health by 58.5% in the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock valued at $124,000 after buying an additional 3,331 shares during the last quarter. Finally, PNC Financial Services Group Inc. boosted its stake in shares of Sotera Health by 39.4% during the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after buying an additional 2,627 shares during the period. Institutional investors and hedge funds own 91.03% of the company's stock.

Sotera Health Price Performance

Shares of SHC stock traded down $0.08 during midday trading on Wednesday, reaching $11.23. 237,413 shares of the company traded hands, compared to its average volume of 1,200,744. The firm's 50 day simple moving average is $11.47 and its two-hundred day simple moving average is $13.10. The firm has a market cap of $3.19 billion, a PE ratio of 44.92 and a beta of 1.88. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08.

Wall Street Analyst Weigh In

A number of research analysts have recently issued reports on the company. Barclays dropped their target price on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Piper Sandler dropped their target price on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a research report on Wednesday, April 23rd. Two investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the company's stock. According to data from MarketBeat, the company currently has a consensus rating of "Moderate Buy" and an average price target of $15.20.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.